TY - JOUR
T1 - Results from a randomized controlled trial testing StressProffen; an application-based stress-management intervention for cancer survivors
AU - Børøsund, Elin
AU - Ehlers, Shawna L.
AU - Varsi, Cecilie
AU - Clark, Matthew M.
AU - Andrykowski, Michael A.
AU - Cvancarova, Milada
AU - Solberg Nes, Lise
N1 - Funding Information:
The Norwegian Cancer Society (# 4602492‐2013); funds from the Department of Digital Health Research at the Oslo University Hospital, Oslo, Norway.
Publisher Copyright:
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Background: In-person cognitive-behavioral stress-management interventions are consistently associated with reduced cancer distress. However, face-to-face delivery is an access barrier for many patients, and there is a need to develop remote-delivered interventions. The current study evaluated the preliminary efficacy of an application (app)-based cancer stress-management intervention, StressProffen, in a randomized controlled trial. Methods: Cancer survivors, maximum 1-year posttreatment (N = 172), were randomized to StressProffen (n = 84) or a usual care control group (n = 88). Participants received a blended delivery care model: (a) one face-to-face introduction session, (b) 10 app-based cognitive-behavioral stress-management modules, and (c) follow-up phone calls at weeks 2-3 and 6-7. Outcome measures included stress (Perceived Stress Scale), anxiety and depression (Hospital Anxiety Depression Scale), and health-related quality of life (HRQoL; Short-Form Health Surveys [SF-36]) at 3-months post-intervention, analyzed with change scores as dependent variables in linear regression models. Results: Participants were primarily women (82%), aged 20-78 years (mean 52, SD 11.2), with mixed cancer types (majority breast cancer; 48%). Analysis of 149 participants completing questionnaires at baseline and 3 months revealed significant intervention effects: decreased stress (mean difference [MD] −2.8; 95% confidence interval [CI], [−5.2 to −0.4]; P =.022) and improved HRQoL (Role Physical MD = 17.7, [CI 3.7-31.3], P =.013; Social Functioning MD = 8.5, [CI 0.7-16.2], P =.034; Role Emotional MD = 19.5, [CI 3.7-35.2], P =.016; Mental Health MD = 6.7, [CI 1.7-11.6], P =.009). No significant changes were observed for anxiety or depression. Conclusions: Digital-based cancer stress-management interventions, such as StressProffen, have the potential to provide easily accessible, effective psychosocial support for cancer survivors.
AB - Background: In-person cognitive-behavioral stress-management interventions are consistently associated with reduced cancer distress. However, face-to-face delivery is an access barrier for many patients, and there is a need to develop remote-delivered interventions. The current study evaluated the preliminary efficacy of an application (app)-based cancer stress-management intervention, StressProffen, in a randomized controlled trial. Methods: Cancer survivors, maximum 1-year posttreatment (N = 172), were randomized to StressProffen (n = 84) or a usual care control group (n = 88). Participants received a blended delivery care model: (a) one face-to-face introduction session, (b) 10 app-based cognitive-behavioral stress-management modules, and (c) follow-up phone calls at weeks 2-3 and 6-7. Outcome measures included stress (Perceived Stress Scale), anxiety and depression (Hospital Anxiety Depression Scale), and health-related quality of life (HRQoL; Short-Form Health Surveys [SF-36]) at 3-months post-intervention, analyzed with change scores as dependent variables in linear regression models. Results: Participants were primarily women (82%), aged 20-78 years (mean 52, SD 11.2), with mixed cancer types (majority breast cancer; 48%). Analysis of 149 participants completing questionnaires at baseline and 3 months revealed significant intervention effects: decreased stress (mean difference [MD] −2.8; 95% confidence interval [CI], [−5.2 to −0.4]; P =.022) and improved HRQoL (Role Physical MD = 17.7, [CI 3.7-31.3], P =.013; Social Functioning MD = 8.5, [CI 0.7-16.2], P =.034; Role Emotional MD = 19.5, [CI 3.7-35.2], P =.016; Mental Health MD = 6.7, [CI 1.7-11.6], P =.009). No significant changes were observed for anxiety or depression. Conclusions: Digital-based cancer stress-management interventions, such as StressProffen, have the potential to provide easily accessible, effective psychosocial support for cancer survivors.
KW - cancer
KW - cancer survivor
KW - cognitive behavioral
KW - digital
KW - distress
KW - health-care delivery
KW - psycho-oncology
KW - stress-management
UR - http://www.scopus.com/inward/record.url?scp=85082977688&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082977688&partnerID=8YFLogxK
U2 - 10.1002/cam4.3000
DO - 10.1002/cam4.3000
M3 - Article
C2 - 32243717
AN - SCOPUS:85082977688
SN - 2045-7634
VL - 9
SP - 3775
EP - 3785
JO - Cancer Medicine
JF - Cancer Medicine
IS - 11
ER -